Heme oxygenase-1 accelerates cutaneous wound healing in mice

PLoS ONE

Volumn 4, Issue 6, 2009, Pages

  Grochot Przeczek, Anna ^a   Lach, Radoslaw ^a   Mis, Jacek ^a   Skrzypek, Klaudia ^a   Gozdecka, Malgorzata ^a   Sroczynska, Patrycja ^a   Dubiel, Milena ^a   Rutkowski, Andrzej ^a   Kozakowska, Magdalena ^a   Zagorska, Arma ^a   Walczynski, Jacek ^a   Was, Halina ^a   Kotlinowski, Jerzy ^a   Drukala, Justyna ^a   Kurowski, Krzysztof ^b   Kieda, Claudine ^c   Herault, Yann ^c   Dulak, Jozef ^a   Jozkowicz, Alicia ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b Adamed Ltd ^*  (Poland)

^c CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CD30 ANTIGEN; CD40 ANTIGEN; CUTANEOUS T CELL ATTRACTING CHEMOKINE; CXCL13 CHEMOKINE; CXCL16 CHEMOKINE; CYTOKERATIN 14; EOTAXIN 2; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GREEN FLUORESCENT PROTEIN; HEME OXYGENASE 1; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 3; LEPTIN; PROTOPORPHYRIN TIN; VASCULOTROPIN; ANGIOGENESIS INHIBITOR; ANTIINFLAMMATORY AGENT; KERATIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; C57BL MOUSE; CONTROLLED STUDY; ENZYME INHIBITION; EPITHELIZATION; GENE EXPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PROTEIN FUNCTION; REEPITHELIZATION; SIDE EFFECT; TRANSGENE; TRANSGENIC MOUSE; UPREGULATION; VASCULARIZATION; VIRAL GENE DELIVERY SYSTEM; WOUND; WOUND CLOSURE; WOUND HEALING; WOUND HEALING IMPAIRMENT; ADENOVIRUS; ANIMAL; EXPERIMENTAL DIABETES MELLITUS; GENE TRANSFER; INFLAMMATION; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROMOTER REGION;

ANIMALIA; MUS; MUS MUSCULUS;

ADENOVIRIDAE; ANGIOGENESIS INHIBITORS; ANIMALS; ANTI-INFLAMMATORY AGENTS; DIABETES MELLITUS, EXPERIMENTAL; GENE TRANSFER TECHNIQUES; HEME OXYGENASE-1; HUMANS; INFLAMMATION; KERATINS; MICE; MICE, INBRED C57BL; PROMOTER REGIONS, GENETIC; TRANSGENES; WOUND HEALING;

EID: 67149129955     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0005803     Document Type: Article

References (77)

1. Gurtner GC, Werner S, Barrandon Y, Longaker MT (2008) Wound repair and regeneration. Nature 453: 314-321.
2. Stadelmann WK, Digenis AG, Tobin GR (1998) Physiology and healing dynamics of chronic cutaneous wounds. Am J Surg 176: 26S-38S.
3. Falanga V (2005) Wound healing and its impairment in the diabetic foot. Lancet 366: 1736-1743.
4. Michaels J, Dobryansky M, Galiano RD, Bhatt KA, Ashinoff R, et al. (2005) Topical vascular endothelial growth factor reverses delayed wound healing secondary to angiogenesis inhibitor administration. Wound Repair Regen 13: 506-512.
5. Bloch W, Huggel K, Sasaki T, Grose R, Bugnon P, et al. (2000) The angiogenesis inhibitor endostatin impairs blood vessel maturation during wound healing. Faseb J 14: 2373-2376.
6. Howdieshell TR, Callaway D, Webb WL, Gaines MD, Procter CD Jr, et al. (2001) Antibody neutralization of vascular endothelial growth factor inhibits wound granulation tissue formation. J Surg Res 96: 173-182.
7. Dickens S, Vermeulen P, Hendrickx B, Van den Berge S, Vranckx JJ (2008) Regulable vascular endothelial growth factor165 overexpression by ex vivo expanded keratinocyte cultures promotes matrix formation, angiogenesis, and healing in porcine full-thickness wounds. Tissue Eng Part A 14: 19-27.
8. Galiano RD, Tepper OM, Pelo CR, Bhatt KA, Callaghan M, et al. (2004) Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells. Am J Pathol 164: 1935-1947.
9. Suh W, Kim KL, Kim JM, Shin IS, Lee YS, et al. (2005) Transplantation of endothelial progenitor cells accelerates dermal wound healing with increased recruitment of monocytes/macrophages and neovascularization. Stem Cells 23: 1571-1578.
10. Maines MD (1997) The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol 37: 517-554.
11. Dulak J, Jozkowicz A, Foresti R, Kasza A, Frick M, et al. (2002) Heme oxygenase activity modulates vascular endothelial growth factor synthesis in vascular smooth muscle cells. Antioxid Redox Signal 4: 229-240.
12. Jozkowicz A, Huk I, Nigisch A, Weigel G, Weidinger F, et al. (2002) Effect of prostaglandin-J(2) on VEGF synthesis depends on the induction of heme oxygenase-1. Antioxid Redox Signal 4: 577-585.
13. Jozkowicz A, Huk I, Nigisch A, Weigel G, Dietrich W, et al. (2003) Heme oxygenase and angiogenic activity of endothelial cells: stimulation by carbon monoxide and inhibition by tin protoporphyrin-IX. Antioxid Redox Signal 5: 155-162.
14. Cisowski J, Loboda A, Jozkowicz A, Chen S, Agarwal A, et al. (2005) Role of heme oxygenase-1 in hydrogen peroxide-induced VEGF synthesis: effect of HO-1 knockout. Biochem Biophys Res Commun 326: 670-676.
15. Suzuki M, Iso-o N, Takeshita S, Tsukamoto K, Mori I, et al. (2003) Facilitated angiogenesis induced by heme oxygenase-1 gene transfer in a rat model of hindlimb ischemia. Biochem Biophys Res Commun 302: 138-143.
16. Sunamura M, Duda DG, Ghattas MH, Lozonschi L, Motoi F, et al. (2003) Heme oxygenase-1 accelerates tumor angiogenesis of human pancreatic cancer. Angiogenesis 6: 15-24.
17. Deshane J, Chen S, Caballero S, Grochot-Przeczek A, Was H, et al. (2007) Stromal cell-derived factor 1 promotes angiogenesis via a heme oxygenase 1-dependent mechanism. J Exp Med 204: 605-618.
18. Hanselmann C, Mauch C, Werner S (2001) Haem oxygenase-1: a novel player in cutaneous wound repair and psoriasis? Biochem J 353: 459-466.
19. Kampfer H, Kolb N, Manderscheid M, Wetzler C, Pfeilschifter J, et al. (2001) Macrophage-derived heme-oxygenase-1: expression, regulation, and possible functions in skin repair. Mol Med 7: 488-498.
20. Platt JL, Nath KA (1998) Heme oxygenase: protective gene or Trojan horse. Nat Med 4: 1364-1365.
21. Jozkowicz A, Dulak J (2003) Effects of protoporphyrins on production of nitric oxide and expression of vascular endothelial growth factor in vascular smooth muscle cells and macrophages. Acta Biochim Pol 50: 69-79.
22. Grundemar L, Ny L (1997) Pitfalls using metalloporphyrins in carbon monoxide research. Trends Pharmacol Sci 18: 193-195.
23. Maines MD (1988) Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications. Faseb J 2: 2557-2568.
24. Loboda A, Jazwa A, Grochot-Przeczek A, Rutkowski A, Cisowski J, et al. (2008): Heme Oxygenase-1 and the Vascular Bed: From Molecular Mechanisms to Therapeutic Opportunities. Antioxid Redox Signal 10: 1767-1812.
25. Wagener FA, van Beurden HE, von den Hoff JW, Adema GJ, Figdor CG (2003) The heme-heme oxygenase system: a molecular switch in wound healing. Blood 102: 521-528.
26. Patil K, Bellner L, Cullaro G, Gotlinger KH, Dunn MW, et al. (2008) Heme oxygenase-1 induction attenuates corneal inflammation and accelerates wound healing after epithelial injury. Invest Ophthalmol Vis Sci 49: 3379-86.
27. Nolan VG, Adewoye A, Baldwin C, Wang L, Ma Q, et al. (1997) Sickle cell leg ulcers: associations with haemolysis and SNPs in Klotho, TEK and genes of the TGF-beta/BMP pathway. Br J Haematol 133: 570-578.
28. Poss KD, Tonegawa S (1997) Heme oxygenase 1 is required for mammalian iron reutilization. Proc Natl Acad Sci U S A 94: 10919-10924.
29. Pittock ST, Norby SM, Grande JP, Croatt AJ, Bren GD, et al. (2005) MCP-1 is upregulated in unstressed and stressed HO-1 knockout mice: Pathophysiologic correlates. Kidney Int 68: 611-622.
30. Poss KD, Tonegawa S (1997) Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natl Acad Sci U S A 94: 10925-10930.
31. Frank C (2004) Approach to skin ulcers in older patients. Can Fam Physician 50: 1653-1659.
32. Thomas M, Tsalamandris C, MacIsaac R, Jerums G (2005) Anaemia in diabetes: an emerging complication of microvascular disease. Curr Diabetes Rev 1: 107-126.
33. Drukala J, Bandura L, Cieslik K, Korohoda W (2001) Locomotion of human skin keratinocytes on polystyrene, fibrin, and collagen substrata and its modification by cell-to-cell contacts. Cell Transplantation 10: 765-771.
34. Jazwa A, Loboda A, Golda S, Cisowski J, Szelag M, et al. (2006) Effect of heme oxygenase-1 on VEGF synthesis and angiogenic potency of human keratinocytes. Free Radical Biol Med 40: 1250-1263.
35. Di Filippo C, Marfella R, Cuzzocrea S, Piegari E, Petronella P, et al. (2005) Hyperglycemia in streptozotocin-induced diabetic rat increases infarct size associated with low levels of myocardial HO-1 during ischemia/reperfusion. Diabetes 54: 803-810.
36. Hayashi K, Haneda M, Koya D, Maeda S, Isshiki K, et al. (2001) Enhancement of glomerular heme oxygenase-1 expression in diabetic rats. Diabetes Res Clin Pract 52: 85-96.
37. Koya D, Hayashi K, Kitada M, Kashiwagi A, Kikkawa R, et al. (2003) Effects of antioxidants in diabetes-induced oxidative stress in the glomeruli of diabetic rats. J Am Soc Nephrol 14: S250-S253.
38. Cukiernik M, Mukherjee S, Downey D, Chakabarti S (2003) Heme oxygenase in the retina in diabetes. Curr Eye Res 27: 301-308.
39. Song F, Qi X, Chen W, Jia W, Yao P, et al. (2007) Effect of Momordica grosvenori on oxidative stress pathways in renal mitochondria of normal and alloxan-induced diabetic mice. Involvement of heme oxygenase-1. Eur J Nutr 46: 61-69.
40. Oksala NK, Lappalainen J, Laaksonen DE, Khanna S, Kaarniranta K, et al. (2007) Alpha-lipoic acid modulates heat shock factor-1 expression in streptozotocin-induced diabetic rat kidney. Antioxid Redox Signal 9: 497-506.
41. Farhangkhoee H, Khan ZA, Mukherjee S, Cukiernik M, Barbin YP, et al. (2003) Heme oxygenase in diabetes-induced oxidative stress in the heart. J Mol Cell Cardiol 35: 1439-1448.
42. Cosso L, Maineri EP, Traverso N, Rosatto N, Pronzato MA, et al. (2001) Induction of heme oxygenase 1 in liver of spontaneously diabetic rats. Free Radic Res 34: 189-191.
43. Avogaro A, Pagnin E, Calo L (2003) Monocyte NADPH oxidase subunit p22(phox) and inducible hemeoxygenase-1 gene expressions are increased in type II diabetic patients: relationship with oxidative stress. J Clin Endocrinol Metab 88: 1753-1759.
44. Calabrese V, Mancuso C, Sapienza M, Puleo E, Calafato S, et al. (2007) Oxidative stress and cellular stress response in diabetic nephropathy. Cell Stress Chaperones 12: 299-306.
45. Song J, Sumiyoshi S, Nakashima Y, Doi Y, Ida M, et al. (2009) Overexpression of heme oxygenase-1 in coronary atherosclerosis of Japanese autopsies with diabetes mellitus: Hisayama study. Atherosclerosis 202(2): 573-81.
46. Rossi S, D'Amico M, Capuano A, Romano M, Petronella P, et al. (2006) Hyperglycemia in streptozotocin-induced diabetes leads to persistent inflammation and tissue damage following uveitis due to reduced levels of ciliary body heme oxygenase-1. Mediators Inflamm 4: 60285.
47. Quan S, Kaminski PM, Yang L, Morita T, Inaba M, et al. (2004) Heme oxygenase-1 prevents superoxide anion-associated endothelial cell sloughing in diabetic rats. Biochem Biophys Res Commun 315: 509-516.
48. Abraham NG, Rezzani R, Rodella L, Kruger A, Taller D, et al. (2004) Overexpression of human heme oxygenase-1 attenuates endothelial cell sloughing in experimental diabetes. Am J Physiol Heart Circ Physiol 287: H2468-H2477.
49. Sambuceti G, Morbelli S, Vanella L, Kusmic C, Marini C, et al. (2009) Diabetes impairs the vascular recruitment of normal stem cells by oxidant damage; Reversed by increases in pAMPK, heme oxygenase-1 and adiponectin. Stem Cells 27(2): 399-407.
50. Moreira TJ, Cebere A, Cebers G, Ostenson CG, Efendic S, et al. (2007) Reduced HO-1 protein expression is associated with more severe neurodegeneration after transient ischemia induced by cortical compression in diabetic Goto-Kakizaki rats. J Cereb Blood Flow Metab 27: 1710-1723.
51. Da Silva JL, Stoltz RA, Dunn MW, Abraham NG, Shibahara S (1997) Diminished heme oxygenase-1 mRNA expression in RPE cells from diabetic donors as quantitated by competitive RT/PCR. Curr Eye Res 16: 380-386.
52. Adaikalakoteswari A, Balasubramanyam M, Rema M, Mohan V (2006) Differential gene expression of NADPH oxidase (p22phox) and hemoxygenase-1 in patients with type 2 diabetes and microangiopathy. Diabet Med 23: 666-674.
53. Bruce CR, Carey AL, Hawley JA, Febbraio MA (2003) Intramuscular heat shock protein 72 and heme oxygenase-1 mRNA are reduced in patients with type 2 diabetes: evidence that insulin resistance is associated with a disturbed antioxidant defense mechanism. Diabetes 52: 2338-2345.
54. Zhang F, Hackett NR, Lam G, Cheng J, Pergolizzi R, et al. (2003) Green fluorescent protein selectively induces HSP70-mediated upregulation of COX-2 expression in endothelial cells. Blood 102: 2115-2121.
55. Ashcroft GS, Mills SJ (2002) Androgen receptor-mediated inhibition of cutaneous wound healing. J Clin Invest 110: 615-624.
56. Gilliver SC, Ashworth JJ, Mills SJ, Hardman MJ, Ashcroft GS (2006) Androgens modulate the inflammatory response during acute wound healing. J Cell Sci 119: 722-732.
57. Goren I, Müller E, Schiefelbein D, Christen U, Pfeilschifter J, et al. (2007) Systemic anti-TNFα treatment restores diabetes-impaired skin repair in ob/ob mice by inactivation of macrophages. J Invest Dermatol 127: 2259-2267.
58. Ojha N, Roy S, He G, Biswas S, Velayutham M, et al. (2008) Assessment of wound-site redox environment and the significance of Rac2 in cutaneous healing. Free Radic Biol Med 44: 682-91.
59. Dulak J, Deshane J, Jozkowicz A, Agarwal A (2008) Heme oxygenase-1 and carbon monoxide in vascular pathobiology. Focus on angiogenesis. Circulation 117: 231-241.
60. Almolki A, Guenegou A, Golda S, Boyer L, Benallaoua M, et al. (2008) Heme oxygenase-1 prevents airway mucus hypersecretion induced by cigarette smoke in rodents and humans. Am J Pathol 173: 981-992.
61. Wu CC, Lu KC, Chen JS, Hsieh HY, Lin SH, et al. (2008) HO-1 induction ameliorates experimental murine membranous nephropathy: anti-oxidative, anti-apoptotic and immunomodulatory effects. Nephrol Dial Transplant 23: 3082-3090.
62. Altavilla D, Galeano M, Bitto A, Minutoli L, Squadrito G, et al. (2005) Lipid peroxidation by raxofelast improves angiogenesis and wound healing in experimental burn wounds. Shock 24: 85-91.
63. Altavilla D, Saitta A, Cucinotta D, Galeano M, Deodato B, et al. (2001) Inhibition of lipid peroxidation restores impaired vascular endothelial growth factor expression and stimulates wound healing and angiogenesis in the genetically diabetic mouse. Diabetes 50: 667-674.
64. Theilla M, Singer P, Cohen J, Dekeyser F (2007) A diet enriched in eicosapentanoic acid, gamma-linolenic acid and antioxidants in the prevention of new pressure ulcer formation incritically ill patients with acute lung injury: a randomize, prospective, controlled study. Clin Nutr 26: 752-757.
65. Shukla A, Rasik AM, Patnaik GK (1997) Depletion of reduced glutathione, ascorbic acid, vitamin E and antioxidant defence enzymes in a healing cutaneous wound. Free Radic Res 26: 93-101.
66. Li Calzi S, Purich DL, Chang KH, Afzal A, Nakagawa T, et al. (2008) Carbon Monoxide and Nitric Oxide Mediate Cytoskeletal Reorganization in Microvascular Cells via Vasodilator-Stimulated Phosphoprotein (VASP) Phosphorylation: Evidence for Blunted Responsiveness in Diabetes. Diabetes 57: 2488-2494.
67. Rossiter H, Barresi C, Pammer J, Rendl M, Haigh J, et al. (2004) Loss of vascular endothelial growth factor activity in murine epidermal keratinocytes delays wound healing and inhibits tumor formation. Cancer Res 64: 3508-3516.
68. Galeano M, Deodato B, Altavilla D, Cucinotta D, Arsic N, et al. (2003) Adeno-associated viral vector-mediated human vascular endothelial growth factor gene transfer stimulates angiogenesis and wound healing in the genetically diabetic mouse. Diabetologia 46: 546-555.
69. Galeano M, Deodato B, Altavilla D, Squadrito G, Seminara P, et al. (2003) Effect of recombinant adeno-associated virus vector-mediated vascular endothelial growth factor gene transfer on wound healing after burn injury. Crit Care Med 31: 1017-1025.
70. Ebrahimian TG, Heymes C, You D, Blanc-Brude O, Mees B, et al. (2006) NADPH oxidase-derived overproduction of reactive oxygen species impairs postischemic neovascularization in mice with type 1 diabetes. Am J Pathol 169: 719-728.
71. Zhao W, Han Q, Lin H, Gao Y, Sun W, et al. (2008) Improved neovascularization and wound repair by targeting human basic fibroblast growth factor (bFGF) to fibrin. J Mol Med 86: 1127-1138.
72. Jozkowicz A, Was H, Dulak J (2007) Heme oxygenase-1 in tumor: is it a false friend? Antioxid Redox Signal 9(12): 2099-117.
73. Minuzzo S, Moserle L, Indraccolo S, Amadori A (2007) Angiogenesis meets immunology: cytokine gene therapy of cancer. Mol Aspects Med 28: 59-86.
74. Honorati MC, Neri S, Cattini L, Facchini A (2006) Interleukin-17, a regulator of angiogenic factor release by synovial fibroblasts. Osteoarthritis Cartilage 14: 345-352.
75. Singh H, Abdullah A, Herndon DN (1992) Effects of rat interleukin-2 and rat interferon on the natural killer cell activity of rat spleen cells after thermal injury. J Burn Care Rehabil 13: 617-22.
76. Moyer KE, Saggers GC, Allison GM, Mackay DR, Ehrlich HP (2002) Effects of interleukin-8 on granulation tissue maturation. J Cell Physiol 193: 173-179.
77. Groves RW, Schmidt-Lucke JA (2000) Recombinant human GM-CSF in the treatment of poorly healing wounds. Adv Skin Wound Care 13: 107-112.